395 related articles for article (PubMed ID: 17536065)
1. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
Navaratna D; McGuire PG; Menicucci G; Das A
Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function.
Behzadian MA; Wang XL; Windsor LJ; Ghaly N; Caldwell RB
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):853-9. PubMed ID: 11222550
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
4. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
6. MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline.
Chen YD; Xu X; Xia X; Wu H; Liu K; Zheng Z; Zhu D
Curr Eye Res; 2008 Nov; 33(11):977-83. PubMed ID: 19085380
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
8. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
12. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
13. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
Sheikpranbabu S; Haribalaganesh R; Lee KJ; Gurunathan S
Biochimie; 2010 Aug; 92(8):1040-51. PubMed ID: 20470857
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
17. Retinal selectivity of gene expression in rat retinal versus brain capillary endothelial cell lines by differential display analysis.
Tomi M; Abukawa H; Nagai Y; Hata T; Takanaga H; Ohtsuki S; Terasaki T; Hosoya K
Mol Vis; 2004 Aug; 10():537-43. PubMed ID: 15316464
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
Friedl J; Turner E; Alexander HR
Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles.
Sheikpranbabu S; Kalishwaralal K; Lee KJ; Vaidyanathan R; Eom SH; Gurunathan S
Biomaterials; 2010 Mar; 31(8):2260-71. PubMed ID: 19963272
[TBL] [Abstract][Full Text] [Related]
20. A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension.
Lopes de Faria JM; Silva KC; Boer PA; Cavalcanti TC; Rosales MA; Ferrari AL; Lopes de Faria JB
Mol Vis; 2008 Sep; 14():1680-91. PubMed ID: 18806882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
